Latest Biotech Financing News

Page 1 of 1

Inhalerx Taps $247K from $38.5M Facility to Fuel Phase 2 Trials

Inhalerx Limited has drawn $247,000 from a $38.5 million funding facility to advance clinical trials for its IRX-211 and IRX-616a drug candidates, reporting positive operating cash flow for the quarter ending June 2025.

Ada Torres

22 July 2025

Top